HER2-positive breast cancer: Combined 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab.

Laura Vincent,Clémentine Jankowski,Marion Cortet,Laurent Arnould,Sylvain Ladoire,Bruno Coudert,Isabelle Desmoulins,Céline Charon-Barra,Françoise Beltjens,Roman Rouzier,Fabien Reyal,Olivier Humbert,Alexandre Cochet,Charles Coutant

HER2-positive breast cancer: Combined 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab.

2019

Laura Vincent
Clémentine Jankowski
Marion Cortet
Laurent Arnould
Sylvain Ladoire
Bruno Coudert
Isabelle Desmoulins
Céline Charon-Barra
Françoise Beltjens
Roman Rouzier
Fabien Reyal
Olivier Humbert
Alexandre Cochet
Charles Coutant

e12095Background: The aim of this study was to compare the value of 18F-fluorodesoxyglucose positron emission tomography (18F-FDG PET/CT) with CGFL/Curie nomogram to predict a pathologic complete r...

Keywords:

Positron emission tomography
Trastuzumab
Nomogram
Curie
HER2 Positive Breast Cancer
Pathology
Radiology
Chemotherapy
Medicine
complete response
18f fdg pet
preoperative chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations